AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
NCT ID: NCT07228689
Last Updated: 2025-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2025-11-12
2027-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Artificial Intelligence (AI) Cytopathology Trial
NCT05018663
EUS-guided Fine Needle Aspiration (EUS-FNA) Versus EUS-guided Fine Needle Biopsy (EUS-FNB) for Diagnosis of Subepithelial Tumors
NCT02943837
EUS-FNA With 22G Procore Needles vs 22G Conventional Needles
NCT01581762
An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study.
NCT06718725
Diagnosis of Pancreatic Cysts: Endoscopic Ultrasound With Fine Needle Aspiration (EUS/FNA), Direct Visualization, and Confocal Laser-induced Endomicroscopy-A Pilot Study
NCT01447238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ChatGPT is a universally available, generative artificial intelligence program developed by OpenAI. The aim of this study is to determine if this AI platform can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretation by cytopathologists as the gold standard.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interpretation of cytology specimen by cytopathologist onsite
The interpretation of the cytology specimens will be made onsite by the cytopathologist
EUS-guided fine needle biopsy
EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract
Interpretation of cytology specimen by artificial intelligence
The interpretation of the cytology specimens will be made onsite by the AI program
EUS-guided fine needle biopsy
EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EUS-guided fine needle biopsy
EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract
Exclusion Criteria
* Patients not undergoing sampling of solid mass lesions at EUS
* Patients with cystic lesions in the gastrointestinal tract
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Orlando Health, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ji Young Bang, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Orlando Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orlando Health Digestive Health Institute
Orlando, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2343877
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.